AIDS 2014 Sneak Preview
July 11, 2014
The 20th International AIDS Conference is just days away. Thousands of community members, clinicians, researchers, policymakers, and others with a stake in the HIV/AIDS response will soon head to Melbourne for this July 20-25 gathering to exchange knowledge around HIV science, policy, prevention, treatment, and prospects for a cure.
So what's in store at AIDS 2014? The conference promises to make headlines on several key themes.
HIV Prevention: TasP and PrEP
Effective antiretroviral (ARV) treatment both improves health for HIV-positive individuals and can dramatically reduce the risk of HIV transmission, an approach known as treatment as prevention, or TasP. At AIDS 2014, a TasP bridging session will explore the latest science on this relatively new approach to curbing new HIV infections, and will offer community and policy perspectives on "best practices" for treatment as prevention.
Also stay tuned for study results on pre-exposure prophylaxis (PrEP), in which HIV-negative people take daily ARVs to cut their risk for acquiring the virus. (Get the facts here.) At AIDS 2014, expect news from the iPrEx OLE study (including qualitative findings about "sex on PrEP"), see results from the multi-site U.S. PrEP Demo Project, and understand prospects for non-daily PrEP use with an update from the Ipergay study.
In addition, "ARV-based HIV Prevention in Practice: Social and Behavioural Aspects," a symposium co-chaired by the San Francisco Department of Public Health's Dr. Al Liu, will address the social and behavioral factors that affect how well ARV-based prevention approaches like treatment as prevention an PrEP will succeed in the "real world" beyond clinical trials.
This excerpt was cross-posted with the permission of BETAblog.org. Read the full article.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.